SCHEMBL16667407

SCHEMBL16667407

N#Cc1cc(-c2ccnc(Nc3ncc(OC(N)=O)o3)n2)ccc1N1CCCC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 12/20 0.51
ROCK2 O75116 2/20 0.42
CDC7 O00311 1/20 0.42
MAP4K4 O95819 1/20 0.42
CDK2 P24941 1/20 0.42
GSK3B P49841 1/20 0.42
CLK4 Q9HAZ1 1/20 0.42
IRAK4 Q9NWZ3 1/20 0.42
IKBKE Q14164 8/20 0.42
KMO O15229 1/20 0.39
MYLK4 Q86YV6 2/20 0.39
STK17A Q9UEE5 2/20 0.39
NEK3 P51956 1/20 0.39
LIMK1 P53667 1/20 0.39
NEK5 Q6P3R8 1/20 0.39
JAK2 O60674 3/20 0.39
JAK3 P52333 2/20 0.39
ROCK1 Q13464 1/20 0.38
CDC42BPB Q9Y5S2 1/20 0.38
JAK1 P23458 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10080689 0.87 TBK1 (0.53) TBK1ROCK2CDC7MAP4K4CDK2
SCHEMBL16667457 0.85 TBK1 (0.51) TBK1ROCK2CDC7MAP4K4CDK2
SCHEMBL10080744 0.84 TBK1 (0.54) TBK1IKBKEKMOMYLK4STK17A
SCHEMBL15307921 0.81 TBK1 (0.49) TBK1IKBKEMYLK4STK17ANEK3
SCHEMBL10080690 0.80 TBK1 (0.53) TBK1ROCK2CDC7MAP4K4CDK2
SCHEMBL16667459 0.80 TBK1 (0.51) TBK1CDK2IKBKE
SCHEMBL459047 0.80 TBK1 (0.49) TBK1ROCK2CDC7MAP4K4CDK2
SCHEMBL16667464 0.79 TBK1 (0.51) TBK1IKBKE
SCHEMBL434250 0.78 TBK1 (0.58) TBK1ROCK2CDK2IKBKEMYLK4
SCHEMBL433957 0.78 TBK1 (0.63) TBK1ROCK2CDK2GSK3BIKBKE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595964-B1 Pyrimidine compounds as inhibitors of protein kinases IKK epsilon and/or TBK-1, processes for their preparation, and pharmaceutical compositions containing them DOMAINEX LTD (GB) 2015-04-29 EP claimed